Raul Torres-Heisecke, MD
Clinical Cardiac Electrophysiology · Tyler, TXNPI 1952518813
Payments from drug & device makers
What this record shows
30 manufacturers reported payments, led by Medtronic at 40.7% of the total. 2025 is the largest year on record at $4,183, 9.7 times the $429 reported in 2019. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in TX, where the typical reported total is $27,892.
Across 354 payments — averaging $37.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$5K
- Abbott$4K
- Novartis$1K
- Boston Scientific$1K
- Atricure, Inc.$522
- Biosense Webster, Inc.$248
- plus $2K from 24 others
Across 180 payments — averaging $3818.88 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Livanova USA, Inc.$310K
- Medtronic$211K
- Cvrx, Inc.$166K
What the payments were for
- Travel & lodging$5,55642%
- Food & beverage$7,76458%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(3 entities) | 83 | $5,420 |
| Abbott | 101 | $3,597 |
| Novartis | 63 | $1,026 |
| Boston Scientific | 20 | $1,000 |
| Atricure, Inc. | 6 | $522 |
| Biosense Webster, Inc. | 10 | $248 |
| Johnson & Johnson(2 entities) | 7 | $184 |
| Cvrx, Inc. | 6 | $181 |
| Pfizer | 8 | $146 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 8 | $134 |
| Merck | 5 | $100 |
| Stryker | 1 | $89 |
| Novo Nordisk | 5 | $83 |
| Irhythm Technologies, Inc. | 4 | $71 |
| E.r. Squibb & Sons, L.L.C. | 4 | $71 |
| Alnylam Pharmaceuticals Inc. | 3 | $67 |
| Philips North America LLC | 2 | $41 |
| Biotronik Inc. | 2 | $39 |
| Siemens Medical Solutions USA, Inc. | 2 | $35 |
| Acutus Medical, Inc. | 1 | $35 |
| Boehringer Ingelheim | 2 | $31 |
| Abiomed | 1 | $31 |
| Altathera Pharmaceuticals LLC | 2 | $30 |
| Bayer | 2 | $27 |
| Baxter Healthcare | 1 | $27 |
| Inari Medical, Inc. | 1 | $25 |
| Cardiva Medical, Inc. | 1 | $21 |
| Amgen | 1 | $19 |
| Esperion Therapeutics, Inc. | 1 | $12 |
| Surmodics, Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$13,320 in reported general payments places this provider in the 25th percentile of 233 clinical cardiac electrophysiology providers in Texas.
See all clinical cardiac electrophysiology providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 632 | $564,769 |
| XareltoRivaroxaban | 172 | $170,793 |
| JardianceEmpagliflozin | 123 | $104,070 |
| MultaqDronedarone Hcl | 50 | $74,597 |
| Dofetilide | 182 | $23,358 |
| EntrestoSacubitril/Valsartan | 32 | $22,157 |
| OzempicSemaglutide | 11 | $10,081 |
| SavaysaEdoxaban Tosylate | 12 | $5,816 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 23 | $4,879 |
| Metoprolol Succinate | 218 | $2,811 |
| Propafenone Hcl | 41 | $1,871 |
| Amiodarone Hcl | 102 | $1,720 |
| Carvedilol | 180 | $1,704 |
| SotalolSotalol Hcl | 77 | $1,465 |
| Potassium Chloride | 87 | $1,457 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $146 | $564,769632 claims |
| Johnson & JohnsonXarelto | $184 | $170,793172 claims |
| Boehringer IngelheimJardiance | $31 | $104,070123 claims |
| NovartisEntresto | $1,026 | $22,15732 claims |
| Novo NordiskOzempic | $83 | $10,08111 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 25th percentile of 233 clinical cardiac electrophysiology providers in Texas.
Other clinical cardiac electrophysiology in Tyler
- John SimsTyler$204K
- Joshua RutlandTyler$168K
- Michael DelaughterBedford$1.6M
- Andrea NataleAustin$1.3M
- Jason ZagrodzkyAustin$961K
- Amin Al-AhmadAustin$771K
- Dale YooMcKinney$585K
- Rodney HortonAustin$553K
- Jose Cuellar SilvaWebster$502K
- Miguel ValderrabanoHouston$461K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.